Drug intelligence / Profile preview

azidocillin

Development stage
Unknown
Modality
Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Administration
Oral
01

Overview

Azidocillin is a narrow-spectrum, semisynthetic penicillin derivative and a member of the beta-lactam antibiotic class. It acts by binding to and inactivating penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis. This inhibition leads to disruption of peptidoglycan cross-linking in the bacterial cell wall and ultimately causes bacterial cell lysis and death. Azidocillin is primarily used for treating infections such as inflammation of the throat, larynx, upper airways, middle ear (otitis media), sinuses (sinusitis), and palatine tonsils. It is excreted mainly unchanged in urine (50–70%), has high plasma protein binding (~84%), and a short half-life (~30 minutes). Side effects are similar to those seen with benzylpenicillin but tend to occur less frequently[7][9][10].

Brand names
Longatren
Other names
azidocillin sodiumAzidocilinaAzidocillineazidocillinumD-(-)-(alpha-Azidobenzyl)penicillin6-(azido-2-phenylacetamido)penicillanic acid
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on azidocillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azidocillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call